Open AccessLong‑term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor‑resistant gastroesophageal reflux disease
Author(s) -
Satoshi Shinozaki,
Hiroyuki Osawa,
Yoshikazu Hayashi,
Yoshimasa Mıura,
Alan Kawarai Lefor,
Hironori Yamamoto
Publication year - 2021
Publication title -
biomedical reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.607
H-Index - 25
eISSN - 2049-9442
pISSN - 2049-9434
DOI - 10.3892/br.2021.1408
Subject(s) - gerd , medicine , gastroenterology , postprandial , constipation , proton pump inhibitor , reflux , diarrhea , disease , insulin